Joseph Okebe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joseph Okebe has a total of 347 co-authors. Here are the top co-authors by number of shared publications:
- Davis Nwakanma
Medical Research Council Unit, Fajara, The Gambia
13 shared publications - Umberto D’aLessandro
Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia
12 shared publications - Kalifa Bojang
Medical Research Council Unit, Fajara, The Gambia
9 shared publications - Alfred Amambua-Ngwa
MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia
8 shared publications - David J. Conway
Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
6 shared publications - Eniyou Cheryll Oriero
MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia
6 shared publications
Latest Publications
- Open Access
- 9 September 2025
- Published by Taylor & Francis in Global Health Action
- Vol. 18 (1) , 2556364
Estimated cost-savings from integrated care for HIV, diabetes and hypertension in sub-Saharan Africa: a cost-minimisation analysis
In a cluster-randomised trial in Uganda and Tanzania, we showed that integrated management, compared with standard vertical care, could achieve a high standard of care for diabetes and hypertension without adversely affecting outcomes for HIV. However, evidence on the value for money of integrated care is needed to inform policy. Our economic evaluation aimed to establish the value for money of integrated care compared with vertical care for HIV, diabetes and hypertension. A societal perspective was adopted, considering provider and patient costs for integrated and standard care in Uganda and Tanzania over one year. Provider costs were estimated for 6714 participants based on five representative health facilities per country. Patient costs were captured via questionnaire from a sub-sample of 2708 participants. Provider costs at scale were estimated using national prevalence and utilisation data. Key inputs were varied in two-way sensitivity analyses. Among participants with single conditions, mean provider and patient costs per patient-visit did not differ significantly between integrated and standard care. Among participants with multiple conditions, mean provider and patient costs per patient-visit were, respectively, Int$18.67 (95%CI 10.89-26.45, p < 0.0001) and Int$5.86 (95%CI 2.57-9.16, p = 0.0005) lower in integrated clinics. If scaled up, integrated care could save providers Int$229 million in Uganda and Int$72 million in Tanzania. From a societal perspective, integrated care for participants with multiple conditions generated mean cost-savings of Int$41.54 (95%CI 29.42-53.67, p < 0.0001) per patient-visit. Integrated care is cost-saving from a societal perspective and should be considered for scale-up in Tanzania, Uganda and similar settings. ISRCTN43896688.
- 9 September 2025
- Published by Taylor & Francis in Global Health Action
- Vol. 18 (1) , 2556364
Open AccessEstimated cost-savings from integrated care for HIV, diabetes and hypertension in sub-Saharan Africa: a cost-minimisation analysis
In a cluster-randomised trial in Uganda and Tanzania, we showed that integrated management, compared with standard vertical care, could achieve a high standard of care for diabetes and hypertension without adversely affecting outcomes for HIV. However, evidence on the value for money of integrated care is needed to inform policy. Our economic evaluation aimed to establish the value for money of integrated care compared with vertical care for HIV, diabetes and hypertension. A societal perspective was adopted, considering provider and patient costs for integrated and standard care in Uganda and Tanzania over one year. Provider costs were estimated for 6714 participants based on five representative health facilities per country. Patient costs were captured via questionnaire from a sub-sample of 2708 participants. Provider costs at scale were estimated using national prevalence and utilisation data. Key inputs were varied in two-way sensitivity analyses. Among participants with single conditions, mean provider and patient costs per patient-visit did not differ significantly between integrated and standard care. Among participants with multiple conditions, mean provider and patient costs per patient-visit were, respectively, Int$18.67 (95%CI 10.89-26.45, p < 0.0001) and Int$5.86 (95%CI 2.57-9.16, p = 0.0005) lower in integrated clinics. If scaled up, integrated care could save providers Int$229 million in Uganda and Int$72 million in Tanzania. From a societal perspective, integrated care for participants with multiple conditions generated mean cost-savings of Int$41.54 (95%CI 29.42-53.67, p < 0.0001) per patient-visit. Integrated care is cost-saving from a societal perspective and should be considered for scale-up in Tanzania, Uganda and similar settings. ISRCTN43896688.
- Open Access
Spatio-temporal trends of molecularly diagnosed clinical malaria cases in The Gambia, captured across sentinel surveillance health facilities
Objectives: Malaria transmission is becoming more heterogeneous across sub-Saharan Africa, and elimination efforts in low-transmission countries are under threat of local or imported antimalarial resistance. The Genomic Surveillance of Malaria (GSM) project established a hub in The Gambia to support malaria elimination efforts through enhanced parasite surveillance as interventions are intensified. We report trends in clinical malaria cases at sentinel sites confirmed by molecular diagnosis over a 4-year period (2019 to 2022). Methods: A total of 10,052 study participants from 383 villages were recruited at 23 health facilities in the six regions of the country. Parasite positivity rates were compared and complexity of infection (COI) was assessed to distinguish spatial and temporal epidemiologically relevant differences. Results: Across the years and all regions, PCR-positive proportions of suspected malaria cases ranged from 9.4% - 73%, with significantly more clinical cases detected in the semi-urban western sites over time. Approximately 12.9% of overall infections detected by PCR were missed by RDT across all regions and there was an upward trend of single-strain P. falciparum infections over the study period. Conclusion: Integrating molecular approaches in routine malaria surveillance provides high-resolution data for prevalence stratification and customized interventions for targeted local malaria elimination strategies.
Open AccessSpatio-temporal trends of molecularly diagnosed clinical malaria cases in The Gambia, captured across sentinel surveillance health facilities
Objectives: Malaria transmission is becoming more heterogeneous across sub-Saharan Africa, and elimination efforts in low-transmission countries are under threat of local or imported antimalarial resistance. The Genomic Surveillance of Malaria (GSM) project established a hub in The Gambia to support malaria elimination efforts through enhanced parasite surveillance as interventions are intensified. We report trends in clinical malaria cases at sentinel sites confirmed by molecular diagnosis over a 4-year period (2019 to 2022). Methods: A total of 10,052 study participants from 383 villages were recruited at 23 health facilities in the six regions of the country. Parasite positivity rates were compared and complexity of infection (COI) was assessed to distinguish spatial and temporal epidemiologically relevant differences. Results: Across the years and all regions, PCR-positive proportions of suspected malaria cases ranged from 9.4% - 73%, with significantly more clinical cases detected in the semi-urban western sites over time. Approximately 12.9% of overall infections detected by PCR were missed by RDT across all regions and there was an upward trend of single-strain P. falciparum infections over the study period. Conclusion: Integrating molecular approaches in routine malaria surveillance provides high-resolution data for prevalence stratification and customized interventions for targeted local malaria elimination strategies.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (2) , 8
Soap and water cleaning versus bleach-based cleaners for eliminating SARS-CoV-2 infection
Background: Households and community settings are important hubs for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As understanding of viral transmission improves, infection prevention and control (IPC) policies need to be updated. Aim: To compare the effectiveness of soap and water alone to bleach-based cleaners in eliminating SARS-CoV-2 infection in households and community settings. Setting: We conducted a virtual search through the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane database of systematic reviews, PubMed, EMBASE, and Effective Practice and Organisation of Care (EPOC). Methods: We assessed studies which compared the effect of soap and water cleaning on SARS-CoV-2 among humans to that of bleach-based cleaning, both in households and communities. We prioritised systematic reviews and randomised studies and only included other study designs, such as laboratory studies, which had interventions of relevant interest. Results: We retrieved 1192 articles from the search. We summarised evidence from three laboratory studies as there were no randomised controlled trials (RCTs) or comparative effectiveness studies that met our inclusion criteria. Indirect evidence suggests that soap and bleach-based cleaners were effective at different concentrations. Substantial heterogeneity between the cited studies precludes any inference on effectiveness in reducing risk of SARS-CoV-2 infection in humans. Both interventions remain important components of IPC measures. Conclusion: There was no evidence for comparison of soap and water versus bleach-based cleaners against SARS-CoV-2 in humans in household and community settings. Indirect evidence shows both interventions to be effective against the virus. Contributions: Primary studies addressing this critical question are required to guide public health recommendations and policies.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (2) , 8
Open AccessSoap and water cleaning versus bleach-based cleaners for eliminating SARS-CoV-2 infection
Background: Households and community settings are important hubs for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As understanding of viral transmission improves, infection prevention and control (IPC) policies need to be updated. Aim: To compare the effectiveness of soap and water alone to bleach-based cleaners in eliminating SARS-CoV-2 infection in households and community settings. Setting: We conducted a virtual search through the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane database of systematic reviews, PubMed, EMBASE, and Effective Practice and Organisation of Care (EPOC). Methods: We assessed studies which compared the effect of soap and water cleaning on SARS-CoV-2 among humans to that of bleach-based cleaning, both in households and communities. We prioritised systematic reviews and randomised studies and only included other study designs, such as laboratory studies, which had interventions of relevant interest. Results: We retrieved 1192 articles from the search. We summarised evidence from three laboratory studies as there were no randomised controlled trials (RCTs) or comparative effectiveness studies that met our inclusion criteria. Indirect evidence suggests that soap and bleach-based cleaners were effective at different concentrations. Substantial heterogeneity between the cited studies precludes any inference on effectiveness in reducing risk of SARS-CoV-2 infection in humans. Both interventions remain important components of IPC measures. Conclusion: There was no evidence for comparison of soap and water versus bleach-based cleaners against SARS-CoV-2 in humans in household and community settings. Indirect evidence shows both interventions to be effective against the virus. Contributions: Primary studies addressing this critical question are required to guide public health recommendations and policies.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (2) , 11
Disinfection methods for preventing COVID-19 infections in healthcare settings: A rapid review
Background: Disinfectant sprays and wipes reduce the risk of infection from contaminated surfaces and materials in healthcare facilities. To support guideline updates, evidence on surface disinfection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are needed. Aim: This study aims to compare the effect of disinfection by spraying or wiping on the risk of human infections in healthcare facilities providing coronavirus disease 2019 (COVID-19) services. Setting: Healthcare settings providing care for patients with COVID-19 or where exposure risk to COVID-19 is high. Method: We searched the Central Register of Controlled Trials (CENTRAL) and Cochrane Database of systematic review; PubMed, EMBASE and EPOC databases from 01 January 2020 to 31 August 2022. Results were screened for eligibility, the risk of bias in included studies assessed, and the certainty of evidence defined using GRADE®. Results: Three observational studies were included. Two studies reporting proportion of surfaces with residual contamination, showed contrasting results with spraying more effective (0%, [n = 0/39] vs. 25.6% [n = 23/90]) in one study but less effective (25.0% [n = 12/48] vs. 48.2% [n = 13/27]) in the other. The third study reported higher reductions from wiping (88.0%) compared to spraying (15.1%). The risk of bias ranged from moderate to serious and the certainty of the evidence was very low. No study reported a direct effect on the risk of infection in humans. Conclusion: Both spraying and wiping methods may protect against SARS-CoV-2 infections indirectly by reducing residual surface contamination. Contribution: The use of both methods of disinfection in cleaning protocols indirectly reduces residual surface contamination.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (2) , 11
Open AccessDisinfection methods for preventing COVID-19 infections in healthcare settings: A rapid review
Background: Disinfectant sprays and wipes reduce the risk of infection from contaminated surfaces and materials in healthcare facilities. To support guideline updates, evidence on surface disinfection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are needed. Aim: This study aims to compare the effect of disinfection by spraying or wiping on the risk of human infections in healthcare facilities providing coronavirus disease 2019 (COVID-19) services. Setting: Healthcare settings providing care for patients with COVID-19 or where exposure risk to COVID-19 is high. Method: We searched the Central Register of Controlled Trials (CENTRAL) and Cochrane Database of systematic review; PubMed, EMBASE and EPOC databases from 01 January 2020 to 31 August 2022. Results were screened for eligibility, the risk of bias in included studies assessed, and the certainty of evidence defined using GRADE®. Results: Three observational studies were included. Two studies reporting proportion of surfaces with residual contamination, showed contrasting results with spraying more effective (0%, [n = 0/39] vs. 25.6% [n = 23/90]) in one study but less effective (25.0% [n = 12/48] vs. 48.2% [n = 13/27]) in the other. The third study reported higher reductions from wiping (88.0%) compared to spraying (15.1%). The risk of bias ranged from moderate to serious and the certainty of the evidence was very low. No study reported a direct effect on the risk of infection in humans. Conclusion: Both spraying and wiping methods may protect against SARS-CoV-2 infections indirectly by reducing residual surface contamination. Contribution: The use of both methods of disinfection in cleaning protocols indirectly reduces residual surface contamination.
- Open Access
- 11 August 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (3) , 8
Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda
Integration of HIV and non-communicable disease (NCD) services is proposed to increase efficiency and coverage of NCD care in sub-Saharan Africa. Between October 2018 to January 2020 in Tanzania and Uganda, working in partnership with health services, we introduced an integrated chronic care model for people with HIV, diabetes and hypertension. In this model, patients were able to access care from a single point of care, as opposed to the standard of siloed care from vertical clinics. When the study ended, routine clinical services adopted the integrated model. In this article, we discuss how the model transitioned post hand-over in Uganda and draw lessons to inform future scale-up. The findings suggest potential for successful uptake of integrated chronic care by routine clinical services in sub-Saharan Africa. This approach may appeal to health care service providers and policy makers when they can quantify benefits that accrue from it, such as optimal utilization of health resources. For patients, integrated care may not appeal to all patients due to HIV-related stigma. Key considerations include good communication with patients, strong leadership, maintaining patient confidentiality and incorporating patient needs to facilitate successful uptake. Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites.
- 11 August 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (3) , 8
Open AccessScaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda
Integration of HIV and non-communicable disease (NCD) services is proposed to increase efficiency and coverage of NCD care in sub-Saharan Africa. Between October 2018 to January 2020 in Tanzania and Uganda, working in partnership with health services, we introduced an integrated chronic care model for people with HIV, diabetes and hypertension. In this model, patients were able to access care from a single point of care, as opposed to the standard of siloed care from vertical clinics. When the study ended, routine clinical services adopted the integrated model. In this article, we discuss how the model transitioned post hand-over in Uganda and draw lessons to inform future scale-up. The findings suggest potential for successful uptake of integrated chronic care by routine clinical services in sub-Saharan Africa. This approach may appeal to health care service providers and policy makers when they can quantify benefits that accrue from it, such as optimal utilization of health resources. For patients, integrated care may not appeal to all patients due to HIV-related stigma. Key considerations include good communication with patients, strong leadership, maintaining patient confidentiality and incorporating patient needs to facilitate successful uptake. Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites.
- Open Access
- 15 June 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (6) , e0000599
Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis
There is an excessive burden of diabetes complications in low-resource settings. We conducted a systematic review to determine the nature and frequency of diabetes complications in newly diagnosed with type 2 diabetes. A systematic search was performed using Medline, CINAHL and Global Health online databases from inception to July 2020. Articles reporting prevalence of microvascular or macrovascular complications within six months of type 2 diabetes diagnosis and published in English or French from low- and middle-income countries (LMICs) were eligible for analysis. Data were extracted using a standardized data extraction tool. Descriptive statistics were used to describe the prevalence of micro and macrovascular complications in newly diagnosed type 2 diabetes. Assessment of heterogeneity was conducted using the inconsistency index (I2) and Cochran-Q chi2statistical tests. Publication bias was assessed by the Funnel plot and Egger test. A total of 3 292 records underwent title or abstract screening and 95 articles underwent full text review. Thirty-three studies describing 13 283 participants (aged 20 years and older) met the inclusion criteria. The eligible studies were from Asia (n = 24), Africa (n = 4), Oceania (n = 2), South America (n = 2) and the Caribbean (n = 1). For microvascular complications, the median prevalence (interquartile range) of retinopathy, nephropathy and neuropathy were 12% (6%-15%), 15% (7%-35%) and 16% (10%25%) respectively. For macrovascular complications, the median prevalence (interquartile range) was 10% (7%-17%) for ischaemic heart disease, 6% (1%-20%) for peripheral arterial disease and 2% (1%-4%) for stroke. There was evidence of substantial heterogeneity between studies for all outcomes (I2> 90%. We found a high prevalence of complications in newly diagnosed type 2 diabetes in LMICs. Findings suggest that many people live with diabetes and are only diagnosed when they present with complications in LMICs. Research is needed to guide timely and effective identification of people living with diabetes in these settings.
- 15 June 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (6) , e0000599
Open AccessPrevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis
There is an excessive burden of diabetes complications in low-resource settings. We conducted a systematic review to determine the nature and frequency of diabetes complications in newly diagnosed with type 2 diabetes. A systematic search was performed using Medline, CINAHL and Global Health online databases from inception to July 2020. Articles reporting prevalence of microvascular or macrovascular complications within six months of type 2 diabetes diagnosis and published in English or French from low- and middle-income countries (LMICs) were eligible for analysis. Data were extracted using a standardized data extraction tool. Descriptive statistics were used to describe the prevalence of micro and macrovascular complications in newly diagnosed type 2 diabetes. Assessment of heterogeneity was conducted using the inconsistency index (I2) and Cochran-Q chi2statistical tests. Publication bias was assessed by the Funnel plot and Egger test. A total of 3 292 records underwent title or abstract screening and 95 articles underwent full text review. Thirty-three studies describing 13 283 participants (aged 20 years and older) met the inclusion criteria. The eligible studies were from Asia (n = 24), Africa (n = 4), Oceania (n = 2), South America (n = 2) and the Caribbean (n = 1). For microvascular complications, the median prevalence (interquartile range) of retinopathy, nephropathy and neuropathy were 12% (6%-15%), 15% (7%-35%) and 16% (10%25%) respectively. For macrovascular complications, the median prevalence (interquartile range) was 10% (7%-17%) for ischaemic heart disease, 6% (1%-20%) for peripheral arterial disease and 2% (1%-4%) for stroke. There was evidence of substantial heterogeneity between studies for all outcomes (I2> 90%. We found a high prevalence of complications in newly diagnosed type 2 diabetes in LMICs. Findings suggest that many people live with diabetes and are only diagnosed when they present with complications in LMICs. Research is needed to guide timely and effective identification of people living with diabetes in these settings.
- Open Access
- 12 May 2022
- Published by Springer Nature in Journal of the Egyptian Public Health Association
- Vol. 97 (1) , 1-5
Malaria rapid diagnostic tests for the case management of febrile children in Nigerian primary healthcare settings: a cross-sectional study
Background: Malaria has been identified as a significant public health burden, exhibiting a high risk of death and morbidity. In sub-Saharan Africa, most young children attending primary healthcare facilities are commonly diagnosed with malaria. Thus, introduction of malaria rapid diagnostic test (mRDT) kits and effective antimalarials has substantially improved the management of malaria cases. However, healthcare worker confidence and adherence to procedures dependent on malaria test results remain variable in high-burden settings due to lacking alternative point-of-care tests to diagnose other causes of fever. In this study, we compared the results of malaria screenings using mRDT and microscopy in febrile children presenting at a primary health facility. Methods: This study was conducted at a primary health center in Owo, Ondo State, Nigeria. Children with fever were assessed for malaria by health staff and, where indicated, screened using Plasmodium falciparum histidine-rich protein-2 mRDT kits. Blood samples were collected on slides for microscopy and in hematocrit tubes for hematocrit determination simultaneously, whereas the mRDT test was done by routine health staff. Children found positive for malaria via mRDT were diagnosed as uncomplicated malaria cases and treated as outpatients using artemether-lumefantrine. Blood slides were read independently by two trained microscopists blinded to the mRDT results. The parasite densities were defined as average counts by both microscopists. We then assessed the sensitivity, specificity, and predictive value of mRDT for the diagnosis of malaria. Results: We compared the test results of 250 febrile children who are under 15 years old. The test positivity rates were 93.6% (234/250) and 97.2% (243/250) using microscopy and rapid RDTs, respectively. The sensitivity and specificity of mRDT compared to microscopy were 100.0% and 43.8%, respectively, with a positive predictive value of 96.3% (95% CI 93.1–98.3). The hematocrit value was <30% in 64% of the children. Conclusion: As per our findings, mRDTs have correctly detected infections in febrile children. Healthcare workers and caregivers should be encouraged to act in accordance with the test results by means of regular feedback on the quality of mRDTs in use in malaria case management.
- 12 May 2022
- Published by Springer Nature in Journal of the Egyptian Public Health Association
- Vol. 97 (1) , 1-5
Open AccessMalaria rapid diagnostic tests for the case management of febrile children in Nigerian primary healthcare settings: a cross-sectional study
Background: Malaria has been identified as a significant public health burden, exhibiting a high risk of death and morbidity. In sub-Saharan Africa, most young children attending primary healthcare facilities are commonly diagnosed with malaria. Thus, introduction of malaria rapid diagnostic test (mRDT) kits and effective antimalarials has substantially improved the management of malaria cases. However, healthcare worker confidence and adherence to procedures dependent on malaria test results remain variable in high-burden settings due to lacking alternative point-of-care tests to diagnose other causes of fever. In this study, we compared the results of malaria screenings using mRDT and microscopy in febrile children presenting at a primary health facility. Methods: This study was conducted at a primary health center in Owo, Ondo State, Nigeria. Children with fever were assessed for malaria by health staff and, where indicated, screened using Plasmodium falciparum histidine-rich protein-2 mRDT kits. Blood samples were collected on slides for microscopy and in hematocrit tubes for hematocrit determination simultaneously, whereas the mRDT test was done by routine health staff. Children found positive for malaria via mRDT were diagnosed as uncomplicated malaria cases and treated as outpatients using artemether-lumefantrine. Blood slides were read independently by two trained microscopists blinded to the mRDT results. The parasite densities were defined as average counts by both microscopists. We then assessed the sensitivity, specificity, and predictive value of mRDT for the diagnosis of malaria. Results: We compared the test results of 250 febrile children who are under 15 years old. The test positivity rates were 93.6% (234/250) and 97.2% (243/250) using microscopy and rapid RDTs, respectively. The sensitivity and specificity of mRDT compared to microscopy were 100.0% and 43.8%, respectively, with a positive predictive value of 96.3% (95% CI 93.1–98.3). The hematocrit value was <30% in 64% of the children. Conclusion: As per our findings, mRDTs have correctly detected infections in febrile children. Healthcare workers and caregivers should be encouraged to act in accordance with the test results by means of regular feedback on the quality of mRDTs in use in malaria case management.
- Open Access
- 16 December 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (1)
Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Ex Vivo Parasite Survival Rate Assay
Monitoring of Plasmodium falciparum sensitivity to antimalarial drugs in Africa is vital for malaria elimination. However, the commonly used ex vivo / in vitro 50% inhibitory concentration (IC 50 ) test gives inconsistent results for several antimalarials, while the alternative ring-stage survival assay (RSA) for artemisinin derivatives has not been widely adopted. Here, we applied an alternative two-color flow cytometry-based parasite survival rate assay (PSRA) to detect ex vivo antimalarial tolerance in P. falciparum isolates from The Gambia.
- 16 December 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (1)
Open AccessTolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Ex Vivo Parasite Survival Rate Assay
Monitoring of Plasmodium falciparum sensitivity to antimalarial drugs in Africa is vital for malaria elimination. However, the commonly used ex vivo / in vitro 50% inhibitory concentration (IC 50 ) test gives inconsistent results for several antimalarials, while the alternative ring-stage survival assay (RSA) for artemisinin derivatives has not been widely adopted. Here, we applied an alternative two-color flow cytometry-based parasite survival rate assay (PSRA) to detect ex vivo antimalarial tolerance in P. falciparum isolates from The Gambia.
- Open Access
- 21 April 2020
- Published by Springer Nature
Evaluating the integration of health services for chronic diseases in Africa
- 21 April 2020
- Published by Springer Nature
Open AccessEvaluating the integration of health services for chronic diseases in Africa
- Open Access
- 20 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Reactive community-based self-administered treatment against residual malaria transmission: study protocol for a randomized controlled trial
Systematic treatment of all individuals living in the same compound of a clinical malaria case may clear asymptomatic infections and possibly reduce malaria transmission, where this is focal. High and sustained coverage is extremely important and requires active community engagement. This study explores a community-based approach to treating malaria case contacts. This is a cluster-randomized trial to determine whether, in low-transmission areas, treating individuals living in the same compound of a clinical malaria case with dihydroartemisinin-piperaquine can reduce parasite carriage and thus residual malaria transmission. Treatment will be administered through the local health system with the approach of encouraging community participation designed and monitored through formative research. The trial goal is to show that this approach can reduce in intervention villages the prevalence of Plasmodium falciparum infection toward the end of the malaria transmission season. Adherence and cooperation of the local communities are critical for the success of mass treatment campaigns aimed at reducing malaria transmission. By exploring community perceptions of the changing trends in malaria burden, existing health systems, and reaction to self-administered treatment, this study will develop and adapt a model for community engagement toward malaria elimination that is cost-effective and fits within the existing health system. Clinical trials.gov, NCT02878200 . Registered on 25 August 2016.
- 20 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Open AccessReactive community-based self-administered treatment against residual malaria transmission: study protocol for a randomized controlled trial
Systematic treatment of all individuals living in the same compound of a clinical malaria case may clear asymptomatic infections and possibly reduce malaria transmission, where this is focal. High and sustained coverage is extremely important and requires active community engagement. This study explores a community-based approach to treating malaria case contacts. This is a cluster-randomized trial to determine whether, in low-transmission areas, treating individuals living in the same compound of a clinical malaria case with dihydroartemisinin-piperaquine can reduce parasite carriage and thus residual malaria transmission. Treatment will be administered through the local health system with the approach of encouraging community participation designed and monitored through formative research. The trial goal is to show that this approach can reduce in intervention villages the prevalence of Plasmodium falciparum infection toward the end of the malaria transmission season. Adherence and cooperation of the local communities are critical for the success of mass treatment campaigns aimed at reducing malaria transmission. By exploring community perceptions of the changing trends in malaria burden, existing health systems, and reaction to self-administered treatment, this study will develop and adapt a model for community engagement toward malaria elimination that is cost-effective and fits within the existing health system. Clinical trials.gov, NCT02878200 . Registered on 25 August 2016.